We are amidst an unprecendented epidemic, a public health emergency. We should not treat this as business as usual.
The best chance of success for any country is to participate in an endeavour which diversifies and broadens access to a broad portfolio of possible vaccine candidates.
Proposals should not come from an angry or frustrated place, and must be evidence-based.
We need to ensure that our actions and motivation are based on empathy, compassion and kindness.
We can follow Perlis and Singapore’s lead in taking similar precautionary measures.
New health challenges such as COVID-19 are inevitable. Our resilience and preparedness to effectively respond depend on sound policies and investments made today.